Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results
Stock Soars on Positive Trial News Celcuity’s stock price skyrocketed on October 20, 2025 after the Minneapolis-based biotech reported game-changing clinical trial results. Shares jumped from around $52 to as high as $78–$81 intraday Marketbeat, an approximately 40–50% single-day leap, before settling near a record high close. This surge marked a new 52-week high of $81.56 Marketbeat and lifted Celcuity’s…